Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Mayo Clinic
100%
Clinical Research Center
100%
Cirrhosis
100%
Liver Cirrhosis
100%
Neutrophils
66%
Placebo
40%
Simvastatin
40%
Statins
38%
Decompensated Cirrhosis
38%
Portal Hypertension
38%
Telomere Length
38%
Hepatic Decompensation
38%
Cirrhosis Complications
38%
Natural History
27%
Telomere Attrition
21%
Telomere Shortening
19%
Magnetic Resonance Elastography
19%
Artificial Intelligence
19%
Multicenter Database
19%
Clinical Translational
19%
Circulating Markers
19%
Fibrosis Regression
19%
Prospective Randomized Trial
19%
Anticoagulation
19%
Improved Outcomes
19%
Electrocardiogram
19%
Length Restoration
19%
Fibrosis
19%
Pathogenic Targets
19%
Disease Progression
19%
Phase I Trial
19%
Longitudinal Data
19%
Cardiovascular Complications
19%
Therapeutic Target
19%
Unique Information
19%
Mechanistic Targets
19%
Natural Outcomes
19%
Multicenter Observational Study
19%
Clinical Laboratory Data
19%
Liver Function
19%
Advanced Liver Disease
19%
Cirrhosis Mortality
19%
Human Studies
19%
Overall Mortality
19%
Prognostic Stage
19%
Portal Pressure
19%
New Therapies
19%
Small Clinical Trials
19%
Thrombosis
19%
Varices
19%
Radiographic Data
19%
Liver
19%
Carcinoma
16%
Attrition
16%
Neutrophil Extracellular Traps
9%
Medicine and Dentistry
Clinical Research
83%
Liver Cirrhosis
83%
Neutrophil
34%
Telomere
27%
Placebo
18%
Simvastatin
18%
Statin
17%
Portal Hypertension
17%
Fibrosis
17%
Decompensated Liver Cirrhosis
17%
Clinical Trial
9%
Median Follow Up
8%
Electrocardiogram
8%
Anticoagulation
8%
Observational Study
8%
Portal Venous Pressure
8%
Disease Exacerbation
8%
Telomere Shortening
8%
Magnetic Resonance Elastography
8%
Cardiovascular Disease
8%
Therapeutic Target
8%
Thrombosis
8%
Liver Function
8%
Diseases
8%
Liver Disease
8%
Human Study
8%
Artificial Intelligence
8%
Varices
8%
Carcinoma
7%
Extracellular Trap
5%
Pharmacology, Toxicology and Pharmaceutical Science
Clinical Research
83%
Liver Cirrhosis
83%
Simvastatin
18%
Placebo
18%
Fibrosis
17%
Portal Hypertension
17%
Decompensated Liver Cirrhosis
17%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
17%
Clinical Trial
9%
Preclinical Study
9%
Thrombosis
8%
Disease Exacerbation
8%
Varicosis
8%
Observational Study
8%
Liver Disease
8%
Diseases
8%
Cardiovascular Disease
8%
Human Study
8%
Carcinoma
7%